View Older Stories View More Recent Stories
-
CryoPort (CYRX) PT Raised to $22 at Roth Capital Following EMA Recommendation
-
Etsy (ETSY) Partnership with DaWanda is Potential Int'l GMS Catalyst
-
Aptose Biosciences (APTO) PT Raised to $7 at Roth Capital
-
Profire Energy (PFIE) Prices 7.5M Share Secondary Public Offering of Common Stock at $3.25/Sh
-
Profire Energy, Inc. Announces Pricing of Secondary Public Offering of Common Stock
-
Adesto Technologies (IOTS) Plans Public Offering of Common Stock
-
Adesto Technologies Corporation Announces Proposed Public Offering of Common Stock
-
CalAmp Corp. (CAMP) PT Lowered to $27 at Roth Capital
-
Roth Capital Starts Q BioMed (QBIO) at Buy
-
Lovesac (LOVE) IPO Opens 56% Higher
-
NTN Buzztime (NTN) Prices 345.78K Share Registered Direct Offering at $4.50/Sh
-
NTN Buzztime Announces $1.6 Million Registered Direct Offering of Common Stock
-
Roth Capital Upgrades JinkoSolar Holding Co., Ltd. (JKS) to Neutral
-
Cree (CREE) PT Raised to $45 at Roth Capital
-
Gentherm Incorporated (THRM) PT Raised to $37 at Roth Capital
-
Lovesac Company (LOVE) Prices 3.5M Share IPO at $16/Sh
-
The Lovesac Company Announces Pricing of Initial Public Offering
-
The Lovesac Company Announces Pricing of Initial Public Offering
-
Veritone, Inc. Announces Closing of Public Offering of Common Stock
-
Roth Capital Resumes Intec Pharma Ltd. (NTEC) at Buy
-
Limoneira Announces Closing of Public Offering and Underwriters’ Full Exercise of Over-Allotment Option
-
Roth Capital Reiterates Buy on First Solar (FSLR) After Meetingh with Management
-
UPDATE: Hudson Technologies (HDSN) PT Lowered to $6 at Roth Capital
-
MeetMe (MEET) PT Raised to $5 at Roth Capital
-
Highpower International Announces Formation of Special Committee
-
Verastem (VSTM) PT Lowered to $10 at Roth Capital
-
Roth Capital Starts Soleno Therapeutics Inc. (SLNO) at Buy
-
Lithium Americas Corp. (LAC) PT Raised to $13 at Roth Capital
-
Akoustis Technologies (AKTS) PT Raised to $10 at Roth Capital
-
Veritone, Inc. (VERI) Prices 1.7M Share Common Stock Offering at $18/Sh
-
Veritone, Inc. Prices Public Offering of Common Stock
-
Moleculin Biotech (MBRX) Reports $2.3 Million Registered Direct Offering Priced At-the-Market
-
Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market
-
Moleculin Announces $2.3 Million Registered Direct Offering Priced At-the-Market
-
Roth Capital Upgrades ReneSola Ltd. (SOl) to Neutral
-
Limoneira (LMNR) Prices Upsized 2.72M Offering of Common Stock at $22/Share
-
Limoneira Announces Pricing of its Upsized Public Offering of Common Stock
-
Veritone, Inc. (VERI) Announces Proposed Common Share Offering
-
Veritone, Inc. Announces Proposed Public Offering of Common Stock
-
Limoneira (LMNR) Announces Proposed $50M Common Share Offering
-
Limoneira Announces Proposed Public Offering of Common Stock
-
Tilray Inc. Announces Filing of a U.S. Registration Statement and Application for Proposed IPO on Nasdaq
-
SolarEdge (SEDG) Optimizers NOT Included in Recent China Tariffs - Roth Capital
-
Roth Capital Starts Evofem Biosciences Inc (EVFM) at Buy
-
Galmed Pharma (GLMD) Prices 5M Share Common Offering at $15/Sh
-
Galmed Pharmaceuticals Ltd. Announces Pricing of Public Offering of Ordinary Shares
-
Asure Software, Inc. Announces Closing of Public Offering of Common Stock
-
ROTH Capital Partners to Host Precious Metals Corporate Access Day in New York on June 26, 2018
-
Roth Capital Starts OptimizeRX (OPRX) at Buy
-
Mitek to Participate in ROTH London Conference

